Regenerative Deeptech
Fortune 500
joint development partners
Commercializing a new biomaterial - from a KTH lab to Fortune 500 supply chains.
Key commercial executive behind two KTH Royal Institute of Technology spin-offs. Led the commercialisation of advanced biomaterial science, securing JDAs with Fortune 500 tier-1 manufacturers in the automotive and footwear industries.









